Hormone Responsibility
Promoting Animal Reproductive Health

R&D Department

Research and Development Department(R&D)

Administration Department

Administration Management Department

Sales Department

Sale Department

Technical Service Department

Technical Service Department

     Ningbo Second Hormone Factory was established in 1988. It is a high-tech enterprise specializing in the production of veterinary reproductive hormones, integrating raw materials, R&D, production, sales and service. Its products are widely used in pigs, cattle, sheep, fish, pets and other fields, and it is one of the companies with the most complete series of veterinary hormone products in China. The company is the first enterprise in the veterinary drug hormone industry to pass the new version of GMP certification, and has successively won the honors of "National High-tech Enterprise", "Zhejiang Province 'Invisible Champion' Cultivation Enterprise", "Ningbo Enterprise Engineering (Technology) Center", "Ningbo 'Specialized, Special and New' Small and Medium-sized Enterprise", "Cixi Top 100 Taxpayers", etc.

     The company has always adhered to the enterprise tenet of "creating excellent quality in the industry and building an international first-class brand", self-developed and produced main raw materials, introduced human drug preparation technology, and overall improved the quality of veterinary hormone preparations. At present, the company's R&D products have cumulatively obtained 19 national new veterinary drug registrations, including 12 national second-class new veterinary drugs; hosted and participated in the formulation of 16 national standards; independently developed and obtained 30 national authorized patents; and maintained 2-3 new veterinary drugs for approval every year. In 2023, the company's buserelin (Buserelin For Injection), Belchi (Carbetocin Injection) raw materials and preparations were respectively approved as national second-class new veterinary drugs; Tongyunbao (Altrenogest Tablets) was approved as a national fourth-class new veterinary drug, with dosage form upgraded, which is an international first; in 2024, the oxytocin raw material drug declared by the company was approved as a national third-class new veterinary drug, filling the gap in the quality standard of domestic veterinary oxytocin raw material drug, which is the first in the domestic veterinary drug industry.

     The company adheres to the combination of independent R&D and industry-university-research cooperation, and jointly develops domestic leading veterinary hormone products and application technologies with well-known domestic universities and scientific research institutes, and strives to create high-quality veterinary hormone products for customers. It has established multiple sets of sow batch production technology, cow synchronous estrus technology, sheep superovulation, synchronous estrus and induced estrus treatment procedures suitable for different breeding scales and application scenarios, providing customers with complete and efficient breeding solutions. The company has always adhered to the mission of "hormone responsibility, promoting animal reproductive health", actively promoted the efficient breeding and innovative development of the domestic breeding industry, and guaranteed human food safety.